比较基因组分析揭示血液恶性肿瘤患者体内碳青霉烯类耐药质粒跨物种转移高发
16例(8.9%)定植或感染多种CRGNB,全基因组测序提示8/10例多种碳青霉烯类耐药肠杆菌目(CRE)患者以种间转移为主。血液恶性肿瘤患者住院期间更易出现多种CRGNB株(OR 3.0,95%CI 0.98-8.89,p 0.05)和CRE株(OR 3.9,95%CI 1.02-14.58,p 0.04)。
要点
- 8.9%患者定植或感染多种CRGNB,以种间质粒转移为主。
- 血液恶性肿瘤患者住院期间多种CRGNB和CRE风险更高。
- 需优化防控措施并指导抗菌药物管理。
核心结论
- 临床环境中自然发生体内水平基因转移(HGT),种间转移是多种CRE的主要机制。
- 血液恶性肿瘤患者住院期间更易出现多种CRGNB和CRE株。
研究设计与样本
- 对16例患者32株多种CRGNB进行全基因组测序质粒内容比对。
主要发现
- 16/179例(8.9%)定植或感染多种CRGNB。
- 11/179例(6.1%)定植多种CRE,5/179例(2.8%)定植碳青霉烯类耐药非发酵菌(CRNF)和CRE。
- 8/10例(80%)多种CRE患者全基因组测序提示种间转移为主,CRNF-CRE组合未见。
- 30/158例住院患者(20%)有血液恶性肿瘤,更易出现多种CRGNB株(OR 3.0,95%CI 0.98-8.89,p 0.05)和CRE株(OR 3.9,95%CI 1.02-14.58,p 0.04)。
临床怎么用
- 对血液恶性肿瘤住院患者加强多种CRGNB监测。
- 理解HGT有助于优化防控措施和抗菌药物管理。
局限性
- 回顾性设计,部分分离株无法回收。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Conjugative gene transfer has been considered as one of the driving factors in the transmission and dissemination of multidrug resistance in bacteria. The abundance of antimicrobial resistance genes and bacteria in the gut microbiome may provide the ideal platform for plasmid exchange. Systematic data on in vivo horizontal gene transfer (HGT) and its frequency are scarce. MATERIALS AND METHODS: One hundred and ninety-six carbapenem-resistant gram-negative bacilli (CRGNBs) from 179 patients (158 inpatients and 21 outpatients) between January 2016 and April 2017 were analysed retrospectively. Alignment of plasmid content for 32 isolates from 16 patients with multiple CRGNB species was performed from whole-genome sequencing (WGS) data. RESULTS: Sixteen of the 179 patients (8.9%) were colonized and/or infected with more than one CRGNB species; 11/179 (6.1%) were colonized by multiple carbapenem-resistant Enterobacteriaceae (CREs) and 5/179 (2.8%) by carbapenem-resistant non-fermenters (CRNFs) and CREs. WGS suggested interspecies transfer as the predominant mechanism rather than independent acquisition in 8/10 patients (80%, one non-recoverable isolate) with multiple CREs but not in CRNF-CRE combinations; 30/158 inpatients (20%) had underlying haematological malignancies, and they are more likely to exhibit multiple CRGNB strains (OR 3.0, 95%CI 0.98-8.89, p 0.05) and CRE strains (OR 3.9, 95%CI 1.02-14.58, p 0.04) during hospital stay compared to other patient groups. CONCLUSION: Our data give insight into the occurrence of natural in vivo HGT in a clinical setting. Better understanding of HGT will help optimize containment measures and may guide antibiotic stewardship programmes.
引用
- Kocer K, Boutin S, Dalpke AH, et al. Comparative genomic analysis reveals a high prevalence of inter-species in vivo transfer of carbapenem-resistance plasmids in patients with haematological malignancies. Clin Microbiol Infect. 2019. PMID: 31654794. doi:10.1016/j.cmi.2019.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。